메뉴 건너뛰기




Volumn 218, Issue 5, 2013, Pages 683-689

Polyvalent immunoglobulin significantly attenuated the formation of IL-1β in Escherichia coli-induced sepsis in pigs

Author keywords

Cytokines; IgGAM; Inflammasome; IVIG; Sepsis

Indexed keywords

CD11 ANTIGEN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

EID: 84875671259     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.08.268     Document Type: Article
Times cited : (21)

References (35)
  • 2
    • 0028024881 scopus 로고
    • Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo
    • Aukrust P., Froland S.S., Liabakk N.B., Muller F., Nordoy I., Haug C., Espevik T. Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo. Blood 1994, 84:2136-2143.
    • (1994) Blood , vol.84 , pp. 2136-2143
    • Aukrust, P.1    Froland, S.S.2    Liabakk, N.B.3    Muller, F.4    Nordoy, I.5    Haug, C.6    Espevik, T.7
  • 3
    • 0028113940 scopus 로고
    • High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments
    • Basta M., Dalakas M.C. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J. Clin. Invest. 1994, 94:1729-1735.
    • (1994) J. Clin. Invest. , vol.94 , pp. 1729-1735
    • Basta, M.1    Dalakas, M.C.2
  • 6
    • 84858615495 scopus 로고    scopus 로고
    • Relationship between the timing of administration of IgM and IgA enriched immunoglobulins in patients with severe sepsis and septic shock and the outcome: a retrospective analysis
    • Berlot G., et al. Relationship between the timing of administration of IgM and IgA enriched immunoglobulins in patients with severe sepsis and septic shock and the outcome: a retrospective analysis. J. Crit. Care 2012, 27:167-171.
    • (2012) J. Crit. Care , vol.27 , pp. 167-171
    • Berlot, G.1
  • 7
    • 33646444174 scopus 로고    scopus 로고
    • Do plasma substitutes have additional properties beyond correcting volume deficits?
    • Boldt J. Do plasma substitutes have additional properties beyond correcting volume deficits?. Shock 2006, 25:103-116.
    • (2006) Shock , vol.25 , pp. 103-116
    • Boldt, J.1
  • 9
    • 38349058657 scopus 로고    scopus 로고
    • Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock
    • Dellinger R.P., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2008, 34:17-60.
    • (2008) Intensive Care Med. , vol.34 , pp. 17-60
    • Dellinger, R.P.1
  • 10
    • 72149125317 scopus 로고    scopus 로고
    • Clinical applications of intravenous immunoglobulins (IVIg) - beyond immunodeficiencies and neurology
    • Hartung H.P., Mouthon L., Ahmed R., Jordan S., Laupland K.B., Jolles S. Clinical applications of intravenous immunoglobulins (IVIg) - beyond immunodeficiencies and neurology. Clin. Exp. Immunol. 2009, 158(Suppl 1):23-33.
    • (2009) Clin. Exp. Immunol. , vol.158 , Issue.SUPPL 1 , pp. 23-33
    • Hartung, H.P.1    Mouthon, L.2    Ahmed, R.3    Jordan, S.4    Laupland, K.B.5    Jolles, S.6
  • 11
    • 0034031005 scopus 로고    scopus 로고
    • Release of Gram-negative outer-membrane proteins into human serum and septic rat blood and their interactions with immunoglobulin in antiserum to Escherichia coli J5
    • Hellman J., Loiselle P.M., Zanzot E.M., Allaire J.E., Tehan M.M., Boyle L.A., Kurnick J.T., Warren H.S. Release of Gram-negative outer-membrane proteins into human serum and septic rat blood and their interactions with immunoglobulin in antiserum to Escherichia coli J5. J. Infect. Dis. 2000, 181:1034-1043.
    • (2000) J. Infect. Dis. , vol.181 , pp. 1034-1043
    • Hellman, J.1    Loiselle, P.M.2    Zanzot, E.M.3    Allaire, J.E.4    Tehan, M.M.5    Boyle, L.A.6    Kurnick, J.T.7    Warren, H.S.8
  • 12
    • 37549057568 scopus 로고    scopus 로고
    • Immunoglobulin M-enriched human intravenous immunoglobulins reduce leukocyte-endothelial cell interactions and attenuate microvascular perfusion failure in normotensive endotoxemia
    • Hoffman J.N., Fertmann J.M., Vollmar B., Laschke M.W., Jauch K.W., Menger M.D. Immunoglobulin M-enriched human intravenous immunoglobulins reduce leukocyte-endothelial cell interactions and attenuate microvascular perfusion failure in normotensive endotoxemia. Shock 2008, 29:133-139.
    • (2008) Shock , vol.29 , pp. 133-139
    • Hoffman, J.N.1    Fertmann, J.M.2    Vollmar, B.3    Laschke, M.W.4    Jauch, K.W.5    Menger, M.D.6
  • 13
    • 80052175401 scopus 로고    scopus 로고
    • Intracellular sensing of microbes and danger signals by the inflammasomes
    • Horvath G.L., Schrum J.E., De Nardo C.M., Latz E. Intracellular sensing of microbes and danger signals by the inflammasomes. Immunol. Rev. 2011, 243:119-135.
    • (2011) Immunol. Rev. , vol.243 , pp. 119-135
    • Horvath, G.L.1    Schrum, J.E.2    De Nardo, C.M.3    Latz, E.4
  • 14
    • 0027242370 scopus 로고
    • Effect of IgM-enriched intravenous immunoglobulin (Pentaglobin) on endotoxaemia and anti-endotoxin antibodies in bone marrow transplantation
    • Jackson S.K., Parton J., Barnes R.A., Poynton C.H., Fegan C. Effect of IgM-enriched intravenous immunoglobulin (Pentaglobin) on endotoxaemia and anti-endotoxin antibodies in bone marrow transplantation. Eur. J. Clin. Invest. 1993, 23:540-545.
    • (1993) Eur. J. Clin. Invest. , vol.23 , pp. 540-545
    • Jackson, S.K.1    Parton, J.2    Barnes, R.A.3    Poynton, C.H.4    Fegan, C.5
  • 15
    • 0035818044 scopus 로고    scopus 로고
    • Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin
    • Kazatchkine M.D., Kaveri S.V. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N. Engl. J. Med. 2001, 345:747-755.
    • (2001) N. Engl. J. Med. , vol.345 , pp. 747-755
    • Kazatchkine, M.D.1    Kaveri, S.V.2
  • 16
    • 36448938357 scopus 로고    scopus 로고
    • Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock
    • Kreymann K.G., de H.G., Nierhaus A., Kluge S. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit. Care Med. 2007, 35:2677-2685.
    • (2007) Crit. Care Med. , vol.35 , pp. 2677-2685
    • Kreymann, K.G.1    de, H.G.2    Nierhaus, A.3    Kluge, S.4
  • 17
    • 0032586346 scopus 로고    scopus 로고
    • Efficacy and potential clinical applications of Pentaglobin, an IgM-enriched immunoglobulin concentrate suitable for intravenous infusion
    • Lissner R., Struff W.G., Autenrieth I.B., Woodcock B.G., Karch H. Efficacy and potential clinical applications of Pentaglobin, an IgM-enriched immunoglobulin concentrate suitable for intravenous infusion. Eur. J. Surg. Suppl. 1999, 17-25.
    • (1999) Eur. J. Surg. Suppl. , pp. 17-25
    • Lissner, R.1    Struff, W.G.2    Autenrieth, I.B.3    Woodcock, B.G.4    Karch, H.5
  • 19
    • 0036721025 scopus 로고    scopus 로고
    • Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation
    • Mollnes T.E., Brekke O.L., Fung M., Fure H., Christiansen D., Bergseth G., Videm V., Lappegard K.T., Kohl J., Lambris J.D. Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 2002, 100:1869-1877.
    • (2002) Blood , vol.100 , pp. 1869-1877
    • Mollnes, T.E.1    Brekke, O.L.2    Fung, M.3    Fure, H.4    Christiansen, D.5    Bergseth, G.6    Videm, V.7    Lappegard, K.T.8    Kohl, J.9    Lambris, J.D.10
  • 20
    • 0028928224 scopus 로고
    • Inhibition of complement-mediated red cell lysis by immunoglobulins is dependent on the IG isotype and its C1 binding properties
    • Mollnes T.E., Hogasen K., Hoaas B.F., Michaelsen T.E., Garred P., Harboe M. Inhibition of complement-mediated red cell lysis by immunoglobulins is dependent on the IG isotype and its C1 binding properties. Scand. J. Immunol. 1995, 41:449-456.
    • (1995) Scand. J. Immunol. , vol.41 , pp. 449-456
    • Mollnes, T.E.1    Hogasen, K.2    Hoaas, B.F.3    Michaelsen, T.E.4    Garred, P.5    Harboe, M.6
  • 22
    • 42649089750 scopus 로고    scopus 로고
    • Anti-inflammatory actions of intravenous immunoglobulin
    • Nimmerjahn F., Ravetch J.V. Anti-inflammatory actions of intravenous immunoglobulin. Annu. Rev. Immunol. 2008, 26:513-533.
    • (2008) Annu. Rev. Immunol. , vol.26 , pp. 513-533
    • Nimmerjahn, F.1    Ravetch, J.V.2
  • 23
    • 79953285696 scopus 로고    scopus 로고
    • Colloids versus crystalloids for fluid resuscitation in critically ill patients
    • Perel P., Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst. Rev. 2011, CD000567.
    • (2011) Cochrane Database Syst. Rev.
    • Perel, P.1    Roberts, I.2
  • 24
    • 34250890817 scopus 로고    scopus 로고
    • Pathophysiology of sepsis
    • Remick D.G. Pathophysiology of sepsis. Am. J. Pathol. 2007, 170:1435-1444.
    • (2007) Am. J. Pathol. , vol.170 , pp. 1435-1444
    • Remick, D.G.1
  • 25
    • 0032938501 scopus 로고    scopus 로고
    • Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation
    • Rieben R., Roos A., Muizert Y., Tinguely C., Gerritsen A.F., Daha M.R. Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation. Blood 1999, 93:942-951.
    • (1999) Blood , vol.93 , pp. 942-951
    • Rieben, R.1    Roos, A.2    Muizert, Y.3    Tinguely, C.4    Gerritsen, A.F.5    Daha, M.R.6
  • 27
    • 0033855231 scopus 로고    scopus 로고
    • Systemic activation of coagulation and fibrynolysis in a porcine model of serogroup A streptococcal shock
    • Saetre T., Lindgaard A.K., Lyberg T. Systemic activation of coagulation and fibrynolysis in a porcine model of serogroup A streptococcal shock. Blood Coagul. Fibrinolysis 2000, 11:433-438.
    • (2000) Blood Coagul. Fibrinolysis , vol.11 , pp. 433-438
    • Saetre, T.1    Lindgaard, A.K.2    Lyberg, T.3
  • 28
    • 84858394440 scopus 로고    scopus 로고
    • Bench-to-bedside review: immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective
    • Shankar-Hari M., Spencer J., Sewell W.A., Rowan K.M., Singer M. Bench-to-bedside review: immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective. Crit. Care 2012, 16:206.
    • (2012) Crit. Care , vol.16 , pp. 206
    • Shankar-Hari, M.1    Spencer, J.2    Sewell, W.A.3    Rowan, K.M.4    Singer, M.5
  • 29
    • 38349166112 scopus 로고    scopus 로고
    • Effects of IGM-enriched solution on polymorphonuclear neutrophil function, bacterial clearance, and lung histology in endotoxemia
    • Stehr S.N., Knels L., Weissflog C., Schober J., Haufe D., Lupp A., Koch T., Heller A.R. Effects of IGM-enriched solution on polymorphonuclear neutrophil function, bacterial clearance, and lung histology in endotoxemia. Shock 2008, 29:167-172.
    • (2008) Shock , vol.29 , pp. 167-172
    • Stehr, S.N.1    Knels, L.2    Weissflog, C.3    Schober, J.4    Haufe, D.5    Lupp, A.6    Koch, T.7    Heller, A.R.8
  • 31
    • 0031929252 scopus 로고    scopus 로고
    • Bacterial lipopolysaccharide (LPS)-specific antibodies in commercial human immunoglobulin preparations: superior antibody content of an IgM-enriched product
    • Trautmann M., Held T.K., Susa M., Karajan M.A., Wulf A., Cross A.S., Marre R. Bacterial lipopolysaccharide (LPS)-specific antibodies in commercial human immunoglobulin preparations: superior antibody content of an IgM-enriched product. Clin. Exp. Immunol. 1998, 111:81-90.
    • (1998) Clin. Exp. Immunol. , vol.111 , pp. 81-90
    • Trautmann, M.1    Held, T.K.2    Susa, M.3    Karajan, M.A.4    Wulf, A.5    Cross, A.S.6    Marre, R.7
  • 32
    • 0036336714 scopus 로고    scopus 로고
    • The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis [ISRCTN28863830]
    • Tugrul S., Ozcan P.E., Akinci O., Seyhun Y., Cagatay A., Cakar N., Esen F. The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis [ISRCTN28863830]. Crit. Care 2002, 6:357-362.
    • (2002) Crit. Care , vol.6 , pp. 357-362
    • Tugrul, S.1    Ozcan, P.E.2    Akinci, O.3    Seyhun, Y.4    Cagatay, A.5    Cakar, N.6    Esen, F.7
  • 33
    • 0015342397 scopus 로고
    • Evaluation of hemoconcentration from hematocrit measurements
    • Van B.W. Evaluation of hemoconcentration from hematocrit measurements. J. Appl. Physiol. 1972, 32:712-713.
    • (1972) J. Appl. Physiol. , vol.32 , pp. 712-713
    • Van, B.W.1
  • 34
    • 0035169276 scopus 로고    scopus 로고
    • Intravenous immunoglobulin for prophylaxis and therapy of sepsis
    • Werdan K. Intravenous immunoglobulin for prophylaxis and therapy of sepsis. Curr. Opin. Crit. Care 2001, 7:354-361.
    • (2001) Curr. Opin. Crit. Care , vol.7 , pp. 354-361
    • Werdan, K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.